Programm 170913



Programm 170913
Speakers and Faculty:
- Prof. Dr. Nikola Petrosillo
Infectious Diseases, Rome
- Prof. Dr. Ingo B. Autenrieth
Clinical Microbiology, Tübingen
- PD Dr. med. Christoph Berg
Infectious Diseases, Tübingen
- Prof. Dr. med. Uwe Frank
Clinical Microbiology, Heidelberg
- Prof. Dr. med. Petra Gastmeier
Clinical Microbiology, Berlin
- Prof. Dr. med. Stephan Harbarth
Infection Control Program, Geneva
- Prof. Dr. med. Winfried V. Kern
Infectious Diseases, Freiburg
- Prof. Dr. med. Nisar P. Malek
Internal Medicine I, CIDiC, Tübingen
- Prof. Dr. med. Frederico Pea
Experimental and Clinical Medicine, Udine
- Prof. Dr. med. Mathias Pletz
Infectious Diseases, Jena
- Prof. Dr. Jesus Rodriguez-Bano
, Infectious Diseases, Sevilla
- Prof. Dr. Med. Evelina Tacconelli
Infectious Diseases, Tübingen
Course Venue:
Hörsaal der Klinik für Kinder und Jugendmedizin
Ebene 3, Hörsaal 126
Universitätsklinikum auf dem Schnarrenberg
Hoppe-Seyler-Str. 1,
72076 Tübingen
Comprehensive Infectious
Disease Center (CIDiC)
Administrative Secretariat
Astrid Lutz-von Platen, M.A.
Comphrehensive Infectious Disease Center (CIDiC)
Elfriede-Aulhorn-Str. 6
72076 Tübingen
+49 (0)7071-2981546 (tuesday, wednesday, thursday)
+49 (0)7071-2925074
per E-Mail: [email protected]
Dr. Niklas Müller
University Hospital Tuebingen
Internal Medicine I
Ottfried-Müller-Str. 10
72076 Tübingen
Registration procedure:
The registration form can be found at at and at the homepage:
Veranstaltungskalender/calendar of events, 16.11.2013
Please return it to the course administrative secretariat by
24. Oktober 2013
There is no Registration Fee.
Attendance Grants
ESCMID provides a number of attendance grants for
ESCMID “young scientist members” (< 35 years old). The
grant covers the travel and the accommodation costs
(maximum per person 500 Euro). Please apply with the
registration form before 03. Oktober 2013 with the following
1. Short application letter explaining your reason for
attending the course.
2. CV including professional affiliation, position, list of
publications, date of birth, educational status.
Grant applicants will be informed about the outcome of their
application by e-mail by 07. Oktober 2013.
Verkehrsverein Tübingen
72016 Tübingen, Postfach 2623
Tel: 07071 / 91360,
Fax: 07071 / 350 70
E-Mail: [email protected]
Antibiotic Awareness,
Quality Prescribing & Infection
Control in Clinical Practice
16. November 2013
Course Objectives
This course provides participants with up-todate background information and focuses on a
practical approach to the treatment of severe
bacterial infections in hospitalized patients. The
course will cover healthcare associated
infection prevention and treatment with
particular emphasis on personalized approach
to the antibiotic treatment and infection control
during routine clinical practice. Experienced
national and international speakers will present
most recent data and stimulate case discussion
within interactive session.
DGI, Deutsche Gesellschaft für Infektiologie
Infectious Diseases, Dept. of Internal
Medicine I, Universitätsklinikum Tübingen
ESCMID, European Society of Clinical
Microbiology and Infectious Diseases
DZIF, Deutsches Zentrum für
Petra Gastmeier
Epidemiology of antibiotic resistance in
Uwe Frank,
Burden of antibiotic resistance
Stephan Harbarth,
MRSA and VRE control: Is it possible to
target zero?
Evelina Tacconelli
European guidelines to control MDR
gram-negative bacteria in hospitalised
Chairs: Evelina Tacconelli
Christoph Berg
Winfried Kern
New antibiotics for MRSA treatment:
where is the evidence?
Jesus Rodriguez-Bano
How to best treat the patient with
infection due to MDR E. coli and
K. pneumoniae?
Nicola Petrosillo
Clinical management of infections due
to MDR-Acinetobacter baumanni
Course Coordinators
Winfried V. Kern, Freiburg, Germany
Evelina Tacconelli, Tübingen, Germany
Chairs: Ingo B. Autenrieth,
Winfried Kern
Nisar P. Malek, Winfried Kern,
Evelina Tacconelli,
Chairs: Winfried Kern,
Evelina Tacconelli
Frederico Pea
Continuous infusion in patients with
severe infections: a PK/PD based
Mathias Pletz
Optimized therapy in severe
sepsis/septic shock: do we need drug
monitoring and individualized
medicine ?
Panel discussion
Three clinical cases: problems and
Winfried Kern, Evelina Tacconelli
Conclusion and farewell